STRO — Sutro Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Sutro Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	198	334	376	317	141
Net Total Accounts Receivable
Net Total Receivables	12.5	7.12	36.1	8.62	3.98
Prepaid Expenses
Total Current Assets	219	353	422	343	151
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	51.6	51.1	44.8	35.9	21.6
Long Term Investments
Other Long Term Assets
Total Assets	341	407	471	387	174
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	41.7	66.5	93.7	132	75.1
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	88.8	190	321	343	306
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	253	217	150	44.6	-132
Total Liabilities & Shareholders' Equity	341	407	471	387	174
Total Common Shares Outstanding